Linagliptin efficacy further established in specific patient populations

Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerab...

November 12, 2013 | Tuesday | News
CSL Behring seeks Japan PMDA approval for Hemophilia drug

Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...

December 22, 2015 | Tuesday | News
Boehringer Ingelheim, Hanmi to co-develop lung cancer drug

Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commer...

July 30, 2015 | Thursday | News
Charleston Laboratories, Daiichi Sankyo receives FDA acceptance for CL-108 NDA

Singapore: New Jersey's Charleston Laboratories Inc and Japanese major Daiichi Sankyo Inc have announced that the US Foo...

June 14, 2016 | Tuesday | News
German firm proceeds on ebola vaccine trial

Singapore: Germany based complex biologics development and manufacturing specialist, ProBioGen, has proceeded on the cli...

June 4, 2015 | Thursday | News
Australian researchers find key gene behind Type 2 Diabetes

A finding, published in the Latin American Herald Tribune, says that a genetic study of people with Down's syndrome help...

May 23, 2016 | Monday | News
Multiple myeloma treatment market to reach $8.9 bn by 2021, analyst

Singapore: Global multiple myeloma treatment market value will expand from $7.3 billion in 2014 to $8.9 billion by 2021,...

August 21, 2015 | Friday | Analysis
Novartis buys GSK's antibody drug, Ofatumumab

Singapore: Novartis has proceeded to acquire all remaining rights of GSK's  Ofatumumab, a fully human monoclonal antibo...

August 21, 2015 | Friday | News
Bionomics files patent application for cancer drug

Singapore: Bionomics, a biopharmaceutical company, has filed a patent application for BNC105 in combination with immune ...

June 16, 2015 | Tuesday | News
Teijin, Pulmagen enter agreement for asthma drug

Singapore: Tokyo-based Teijin Pharma, the core company of the Teijin Group's healthcare business, and Pulmagen Therapeu...

September 28, 2012 | Friday | News
FDA approves Novartis' drug for rare blood disorder

Singapore: Novartis has recieved USFDA approval for Promacta (eltrombopag) for the treatment of children six years and o...

June 13, 2015 | Saturday | Regulatory
Agilent, Queensland univ join hands for cancer research

Singapore: Agilent Technologies plans to collaborate with the University of Queensland Center for Clinical Research in B...

November 21, 2013 | Thursday | News
CrystalGenomics partners with Dong-A for Acelex commercialization

Singapore: Korea based CrystalGenomics has signed a sales and marketing agreement with Dong-A ST for the commercializati...

August 14, 2015 | Friday | News
Japanese researchers discover potential drug target for muscle disease

Tokyo: In collaboration with the Institute for Frontier Medical Sciences at Kyoto University, a team of CiRA researchers...

August 24, 2015 | Monday | News
AMRI acquires spanish API firm at $174 mn

Singapore: AMRI has acquired all the outstanding shares of Spanish firm, Gadea Pharmaceutical Group, specializing in tec...

July 20, 2015 | Monday | News
Kowa, Chugai to market liver cancer drug

Singapore: Japan's Kowa Company and Chugai Pharmaceutical have entered into license agreement for liver cancer drug pere...

July 21, 2015 | Tuesday | News
SCIEX expands lipidomics portfolio

Singapore: SCIEX, a life science analytical technologies provider, and Metabolon, a global company focused on metabolomi...

June 17, 2015 | Wednesday | News
RaQualia, Interprotein to research on pain drug

Singapore: RaQualia Pharma and Interprotein entered into a collaborative research agreement. The partnership will focus...

February 4, 2013 | Monday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls